ESHAP and G-CSF is a superior blood stem cell mobilizing regimen compared to cyclophosphamide 1.5 g m(−2) and G-CSF for pre-treated lymphoma patients: a matched pairs analysis of 7...

por Watts, M J, Ings, S J, Leverett, D, MacMillan, A, Devereux, S, Goldstone, A H, Linch, D C
Publicado 2000

High-dose BEAM chemotherapy with autologous haemopoietic stem cell transplantation for Hodgkin's disease is unlikely to be associated with a major increased risk of secondary MDS/A...

por Harrison, C N, Gregory, W, Hudson, G Vaughan, Devereux, S, Goldstone, A H, Hancock, B, Winfield, D, MacMillan, A K, Hoskin, P, Newland, A C, Milligan, D, Linch, D C
Publicado 1999